1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 6,150 | 6,300 | 10.09. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.07. | XFRA 1AU: WIEDERAUFNAHME/RESUMPTION | 84 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 29.07. | Zydus Announces Completion of the Acquisition of an 85.6% Stake in Amplitude Surgical and Upcoming Filing of a Simplified Tender Offer | 340 | Business Wire | Regulatory News:
Zydus Lifesciences Limited1 ("Zydus"), on March 11, 2025, entered into agreements with PAI and two minority shareholders of Amplitude Surgical (Paris:AMPLI) to acquire blocks of... ► Artikel lesen | |
| 29.07. | XFRA 1AU: AUSSETZUNG/SUSPENSION | 166 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILAMPLITUDE SURGIC.... ► Artikel lesen | |
| 29.07. | Amplitude Surgical - Suspension of Listing | 327 | Business Wire | Regulatory News:
Amplitude Surgical company has requested Euronext to suspend the listing of its shares (ISIN: FR0012789667, Ticker: AMPLI, eligible PEA-PME) on Euronext market with effect as from... ► Artikel lesen | |
| AMPLITUDE SURGICAL Aktie jetzt für 0€ handeln | |||||
| 24.07. | Amplitude Surgical - Consolidated annual revenue of €110.8 million, up +5.7% at constant exchange rates | 253 | Business Wire | Business growth of +3.8% at constant exchange rates in the fourth quarter of the 2024-25 financial year and of +5.7% for the full year
Strong momentum in France: revenue up +4.8%
Solid... ► Artikel lesen | |
| 25.04. | Zydus Lifesciences Limited Signs Purchase Agreement with PAI Partners and Other Shareholders to Acquire a Majority Stake in Amplitude Surgical SA | 378 | Business Wire | Regulatory News:
Amplitude Surgical SA (Paris:AMPLI):
Following the joint announcement of March 11, 2025, Zydus Lifesciences Limited ("Zydus") and Amplitude Surgical SA (Paris:AMPLI) ("Amplitude")... ► Artikel lesen | |
| 17.04. | Amplitude Surgical - 9-Months Consolidated Sales for FY 2024-25 of €83.8m, up +6.4% at Constant Exchange Rates | 311 | Business Wire | Sales up +6.6% at constant exchange rates in Q3 FY 2024-25
Consolidated sales for 9 months up+ 6.4% at constant exchange rates to €83.8m
Good momentum in France: sales up +4.7% over... ► Artikel lesen | |
| 17.04. | Zydus Lifesciences Limited announces the execution of undertakings to tender as part of its envisaged tender offer for Amplitude Surgical SA shares | 300 | PR Newswire | AHMEDABAD, India and PARIS, April 17, 2025 /PRNewswire/ -- Following the announcement of its envisaged tender offer on March 11, 2025, Zydus Lifesciences Limited announces the execution of... ► Artikel lesen | |
| 17.04. | Amplitude Surgical Has Been Informed by Zydus Lifesciences Limited of the Execution of Undertakings to Tender as Part of Its Envisaged Tender Offer for Amplitude Surgical SA Shares | 267 | Business Wire | Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible).
Following the announcement of the envisaged tender offer on March 11, 2025 of Zydus Lifesciences Limited... ► Artikel lesen | |
| 26.03. | Amplitude Surgical Announces H1 2024-25 Results: 51.5 M€ Sales and 13.1 M€ EBITDA | 414 | Business Wire | Consolidated sales of €51.5m, up 6.3% at constant exchange rates
EBITDA up 10.6% to €13.1 million, EBITDA margin 25.4%
Current operating income of €6.0 million
Cash position... ► Artikel lesen | |
| 12.03. | XFRA 1AU: WIEDERAUFNAHME/RESUMPTION | 229 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 11.03. | XFRA 1AU: AUSSETZUNG/SUSPENSION | 235 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILAMPLITUDE SURGIC.... ► Artikel lesen | |
| 11.03. | Zydus Enters Exclusive Negotiations with PAI Partners and Other Shareholders to Acquire a Majority stake in Amplitude Surgical, France | 408 | Business Wire | Completion of the transaction to be followed by mandatory simplified tender offer
Zydus has entered into exclusive negotiations to acquire a controlling shareholding in Amplitude Surgical,... ► Artikel lesen | |
| 20.02. | Amplitude Surgical - 1st Half-year 2024-25: Consolidated Sales of €51.5m, +6.3% at Constant Exchange Rates | 339 | Business Wire | Consolidated sales of €51.5 million, up+ 6.3% at constant exchange rates
Good sales growth in France at +4.6%
Strong growth in international business thanks to subsidiaries, with... ► Artikel lesen | |
| 21.11.24 | Amplitude Surgical - First Quarter 2024-25: Consolidated Sales of €21.8m, +7.5% at Constant Exchange Rates | 592 | Business Wire | VALENCE, France--(BUSINESS WIRE)--Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics... ► Artikel lesen | |
| 20.11.24 | Amplitude Surgical Announces Its 2024-25 Financial Calendar | 135 | Business Wire | Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics, announces its financial agenda... ► Artikel lesen | |
| 23.10.24 | Amplitude Surgical - Fiscal Year 2023-24: 106.0 M€ Sales and €27.1m EBITDA | 513 | Business Wire | Consolidated sales of €106.0 million, up 6.3% at constant exchange rates
EBITDA up to €27.1m (+3.7%), EBITDA rate at 25.6%.
Current operating income of €12.7 million
Cash... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BICO GROUP | 2,174 | -0,18 % | Schock-News für Bico Group Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
| PING AN HEALTHCARE | 2,516 | +1,49 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor (1833.HK) Reports Solid Interim Results with Steady Revenue and Profit Growth | HONG KONG, Aug. 20, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (the "Company"; Stock Code: 1833.HK) announced its interim results for the six months ended June... ► Artikel lesen | |
| ORGANON | 8,796 | +0,25 % | Dividendenbekanntmachungen (15.08.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A10 NETWORKS INC US0021211018 0,06 USD 0,0514 EUR AGCO CORPORATION US0010841023 0,29 USD 0,2489 EUR ALBEMARLE CORPORATION PREF... ► Artikel lesen | |
| EMEIS | 11,750 | +0,69 % | emeis: Sales and Business Update at the End of June 20251 | Sustained growth in operating margins
Sustained revenue growth
+6.2% on a like-for-like basis
Net operational recovery
EBITDAR up nearly +20% on a like-for-like basis
EBITDA (excluding... ► Artikel lesen | |
| CYTOSORBENTS | 0,853 | +5,96 % | CytoSorbents bei H.C. Wainwright: Strategisches Wachstum und regulatorische Herausforderungen | ||
| CLARIANE | 4,004 | -0,20 % | Korian Stiftungsaward 2025 geht an vielfältig. GmbH Bremen - erster ambulanter Pflegedienst mit Fokus auf Sexualität und Vielfalt | München (ots) - Der diesjährige Korian Stiftungsaward für Vielfalt und Respekt in der Pflege der Korian Stiftung für Pflege und würdevolles Altern, geht an vielfältig. Bremen. Der ambulante Pflegedienst... ► Artikel lesen | |
| ARJO | 3,106 | +0,98 % | Arjo AB: Christofer Carlsson appointed permanent CFO of Arjo | Arjo announces today that Christofer Carlsson, who has been interim CFO since January 20, 2025, has been appointed permanent CFO of the company starting September 1st.
Christofer has been with Arjo... ► Artikel lesen | |
| M3 INC | 13,800 | +3,76 % | Deutliches Plus erfreut Inhaber der M3-Aktie (12,50 €) | Grund zur Freude haben Aktionäre von M3 : Das Papier steigt deutlich. Zu den stärksten Werten des Tages gehört heute der Anteilsschein von M3 mit einem Wertanstieg von 11,61 Prozent. Für das Papier... ► Artikel lesen | |
| DYNAVOX GROUP | 11,190 | +1,45 % | Dynavox Group AB: Dynavox Group Interim Report second quarter 2025 | Dynavox Group AB (publ) today announced its results for the second quarter 2025.
Comment from the Dynavox Group CEO Fredrik Ruben:
Dynavox Group delivered another quarter of exceptional growth and... ► Artikel lesen | |
| NYXOAH | 4,870 | -1,02 % | Nyxoah SA - 6-K, Report of foreign issuer | ||
| INTERPACE BIOSCIENCES | 0,635 | 0,00 % | Interpace Biosciences, Inc.: Effective May 2, 2025, Interpace Diagnostics Will No Longer Accept Specimens for PancraGEN, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk | Interpace Expects to Remain Profitable as a Thyroid-focused Business PARSIPPANY, NJ, April 24, 2025 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, ("Interpace"... ► Artikel lesen | |
| CHINA MEDICAL SYSTEM | 1,540 | -0,65 % | China Medical System Holdings Ltd.: CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers | SHENZHEN, CHINA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- On 18 August, China Medical System Holdings Limited ("CMS" or the "Company") announced its interim results for the six months ended 30 June 2025... ► Artikel lesen | |
| NANOSONICS | 2,140 | 0,00 % | Nanosonics Director McIntyre to Step Down | ||
| VIVANI MEDICAL | 1,130 | +6,60 % | Vivani Medical stock holds Buy rating at H.C. Wainwright on NPM-139 plans | ||
| NIAGEN BIOSCIENCE | 7,850 | -4,27 % | Niagen Bioscience, Inc: Niagen Bioscience to Participate at the Roth 15th Annual London Conference | Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces... ► Artikel lesen |
AMPLITUDE SURGICAL gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +0,82 % bei einem Aktienkurs von 6,150 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AMPLITUDE SURGICAL finden Sie auf Wallstreet Online.